Terry P. Gould

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Redwood City, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Leiv Lea, as Attorney-in-Fact for Terry P. Gould
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Terry P. Gould

Form 4 holding Director, 10%+ Owner

Corvus Pharmaceuticals, Inc.

Security class
Common Stock, $0.0001 par value
Shares / value
3,275,616
Estimated value
$5,670,746
Report date
13 Jun 2024
Price
$1.73
Ownership
By Funds
Form 4 holding Director

Icosavax, Inc.

Security class
Common Stock
Shares / value
256,783
Estimated value
$4,024,432
Report date
02 Aug 2021
Price
$15.67
Ownership
Indirect
Form 4 holding Director

Aptinyx Inc.

Security class
Stock Option (Right to Buy)
Shares / value
40,000
Estimated value
Report date
26 May 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

Corvus Pharmaceuticals, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,000
Estimated value
Report date
13 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Icosavax, Inc.

Security class
Series A-1 Preferred Stock
Shares / value
0
Estimated value
Report date
02 Aug 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Icosavax, Inc.

Security class
Series B-1 Preferred Stock
Shares / value
0
Estimated value
Report date
02 Aug 2021
Price
Ownership
Indirect
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Terry P. Gould

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .